To explore potential mechanisms underlying the tumor immune microenvironment, we utilized a publicly available scRNA-seq (single-cell RNA-seq) dataset to investigate the expression of ARL4C across various immune cell types. The gene discussed is ARL4C; the disease is neoplasm.